Ablative carbon dioxide laser effective for rhinophyma

Ablative carbon dioxide laser effective for rhinophyma
Good cosmetic outcomes are possible using fractionated ablative carbon dioxide laser therapy for mild-to-moderate cases of rhinophyma, according to research published online Oct. 5 in Lasers in Surgery and Medicine.

(HealthDay)—Good cosmetic outcomes are possible using fractionated ablative carbon dioxide laser therapy for mild-to-moderate cases of rhinophyma, according to research published online Oct. 5 in Lasers in Surgery and Medicine.

Kathryn L. Serowka, M.D., of the University of California in Irvine, and colleagues reported treatment of mild-to-moderate rhinophyma in five patients using aggressive parameters with fractionated ablative laser therapy.

The researchers found that all of the patients, who had relatively mild-to-moderate signs of rhinophyma, tolerated the well. Reepithelialization and self-limited edema and erythema occurred at four to seven days. No adverse events were reported. Patients and physicians observed improved appearance without the typical scarring caused by most other treatments.

"We were able to demonstrate good improvement in texture, color, and size of mild-to-moderate rhinophyma treated with ablative fractionated ," the authors write.

Two authors disclosed financial ties to medical device companies.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Cold-air anesthesia reduces pain of laser treatment

Jun 22, 2012

(HealthDay) -- In ablative fractionated carbon-dioxide (CO2) laser treatment for photoaging, cold-air anesthesia used in conjunction with topical anesthesia reduces pain significantly more than topical an ...

Combo pulsed, non-ablative laser treatment is safe

Aug 20, 2013

(HealthDay)—For facial rejuvenation, a combination treatment of an optimized intense pulsed light source and a non-ablative fractional laser is safe and effective, according to a study published in the ...

Novel approach found for treating hypertrophic scars

Mar 27, 2013

(HealthDay)—Same-session therapy with fractional ablative laser treatment followed immediately with topical application of triamcinolone acetonide suspension is effective in treating patients with hypertrophic ...

Latrepirdine not effective in Huntington's disease

Nov 01, 2012

(HealthDay)—Although safe and well tolerated, the experimental small molecule latrepirdine does not improve cognition after six months of treatment in patients with mild-to-moderate Huntington's disease ...

Recommended for you

Preemptive celecoxib cuts post-op face-lift surgery pain

Jul 23, 2014

(HealthDay)—Preemptive treatment with oral celecoxib appears to be effective in decreasing acute postoperative pain in patients undergoing face-lift surgery, according to a study published online July 10 in JAMA Facial Pl ...

Decompression surgery linked to reduced risk of falls

Jul 22, 2014

(HealthDay)—Decompression surgery in patients with lumbar spinal stenosis cuts their risk of falls, compared to similar patients utilizing nonsurgical interventions, according to a study published in the ...

Activity level may predict orthopedic outcomes

Jul 22, 2014

According to a literature review in the July issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS), patients' activity level is a strong predictor for how well they will do with certain treatments an ...

User comments